Guy M. Goodwin

Clinical Psychology · 2001–2022

A researcher in the Science corpus: 12 papers; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Guy M. Goodwin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. John R. Geddes
  2. J. Bostwick
  3. David J. Nutt
  4. Robin L. Carhart-Harris
  5. Mark William Woolrich
  6. Matthew W. Johnson

Who trusts Guy M. Goodwin overall

  1. Robin L. Carhart-Harris

Papers from Guy M. Goodwin's perspective

Ordered by how strongly the researchers Guy M. Goodwin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Human Hallucinogen Research: Guidelines for Safety (Journal of Psychopharmacology)
  2. Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction (Journal of Psychopharmacology)
  3. Drug harms in the UK: a multicriteria decision analysis. (The Lancet)
  4. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. (Lancet psychiatry)
  5. Affective disorders and suicide risk: a reexamination. (American Journal of Psychiatry)
  6. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (Journal of Psychopharmacology)
  7. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. (Journal of Clinical Psychiatry)
  8. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database. (Archives of General Psychiatry)
  9. Complex brain networks: graph theoretical analysis of structural and functional systems
  10. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (Psychopharmacology)

Their papers